Classification of Peroxisomal Disorders
NeuroLearn NeuroHelp Metabolic @
Peroxisomes: peroxisomes are ubiquitous membrane bound
subcellular organes that participate in multiple metabolic processes. They are
biochemically defined by the presence of a catalase and several oxidases, which
can also be recognized by immunohistochemistry. They are more numerous in cells
that specialize in the metabolism of complex lipids and in the developing
nervous system than in other mature cells.
Principal
biochemical pathways:
Head
Peroxisomal b-oxidation: the main substrates are very-long-chain-fatty acid
(VLCFAs) and trihydroxycholestanoic acids (THCA) which are intermediate
substrate in bile acid synthesis from cholesterol, pristanic acid and
long-chain dicarboxylic acids.
Plasmalogen biosynthesis: Plasmalogens belong to a special class of
phospholipids. Their role is unknown, but they are especially abundant in
the CNS.
Phytanic oxidation: Phytanic acid is a branched-chain fatty acid
derived from dietary sources. It is degraded into pristinic acid through a-oxidation. Pristinic acid is further metabolized
via the peroxisomal b-oxidation
pathway.
Pipecolic catabolism: L-pipecolate oxidase is a peroximal enzyme which
catalyses the hydrogenation of L-pipecolate.
Classification
of peroxisomal disorders:
Group
I (Assembly deficiencies):
Head
Pathogenesis:
The salient pathologic features of this group is failure in the
biogenesis (assembly) of peroxisomes. Loss
of multiple peroxisomal enzyme activities often associated with
morphological abnormalities of the organelle. Trilaminar inclusions within
lysosomes can be seen under electron microscope.
Biochemistry: Many of the disorders in this group are due to defects in importing the protein into the peroxisomes resulting in defective peroxisomal biogenesis or defects in maintaining peroxisomal intergrity.
Genetics:
This group constitutes the generalized peroxisomal disorders and are
inherited as autosomal recessive traits. The incidence in newborn is about
1:50,000 live births.
Entities include:
Pseudo-infantile Refsum’s disease
Zellweger-like syndrome
Group II
(Single enzyme deficiency):
The structure of peroxisomes is intact and only one defective enzyme is
involved. Head
Group IIa: Single peroxisomal enzyme
deficiency
involving b-oxidation
pathway
Pseudo-neonatal adrenoleukodystrophy (Acyl-CoA oxidase)*
Pseudo-Zellweger
(Thiolase)
Bifuctional
enzyme deficiency (Bifunctional protein)
*
Group IIb: Single peroxisomal enzyme
deficiency
without involving b-oxidation
pathway
Pseudo-rhizomelic
chondrodysplasia (Plasmalogen synthesis)
Di-(tri)-hydrocholestanoic
acidemia (Bile acid synthesis)
Mevalonic
aciduria (Cholesterol synthesis)
* Neonatal onset: These peroxisomal disorders have neonatal onset (connatal peroxisomal disorders). They are autosomal recessive disorders with typical clinical features including multiple dysplastic features, and pathological features including neuronal migration defects combined with degenerative changes.
Short note: Head
Infantile Refsum’s
disease: They present as mild Zellweger’s syndrome and
have increase in serum phytanic acid. Hepatic cells contain no peroxisomes;
stacks of angulated trilaminar inclusions can be seen in lysosomes under
electron microscope. Micronodular cirrhosis is also a feature of this this
disease. Adrenal glands are small
but contain no ballooned cells and have no abnormal lipid profiles on electron
microscope. No renal cyst. Optic nerves show no demyelination.
Hyperpipecolic
acidemia:
It has close resemblance to the Zellweger’s syndrome, neonatal
adrenoleukidystrophy and infantile Refsum’s disease and may represent a
variant of one of these entities. Serum pipecolic acid level is increased.
Increases in pipecolic acid in liver and brain have also been documented.
Rhizomelic
chondrodysplasia punctata (RCDP): This is a bone dysplasia with
rhizomelic dwarfism, facial dysmorphism, congential cataract, joint contractures,
severe epiphyseal and extraepiphyseal calcification, mental retardation,
hepatomegaly, and ichthyosis. Peroxisomes may be intact in fibroblasts but
abnormally shaped or totally absent in liver. This entity is clinically
heterogenous and has variants.
NeuroLearn NeuroHelp Metabolic For Comment: KarMing-Fung@ouhsc.edu